1.Andrews, DW, Scott, CB, Sperduto, PW, et al. Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 radomised trial. Lancet. 2004; 363: 1665–1672.
2.Patchell, RA, Tibbs, PA, Regine, WF, et al. Postoperative radiotherapy in the treatment of single metastases to the brain: a randomized trial. J Am Med Assoc. 1998; 280: 1485–1489.
3.Chow, E, Davis, L, Holden, L, Tsao, M, Danjoux, C. Prospective assessment of patient-rated symptoms following whole-brain radiotherapy for brain metastases. J Pain Symptom Manage. 2005; 30: 18–23.
4.Kondziolka, D, Niranjan, A, Flickinger, JC, Lunsford, LD. Radiosurgery with or without whole-brain radiotherapy for brain metastases: the patients’ perspective regarding complications. Am J Clin Oncol. 2005; 28: 173–179.
5.Kocher, M, Soffietti, R, Abacioglu, U, et al. Adjuvent whole-brain radiotherapy versus observation after radiosurgery or surgical resection of one to three cerebral metastases: results of the EROTC 22953-26001 study. J Clin Oncol. 2011; 29: 134–141.
6.Chang, EL, Wefel, JS, Hess, KR, et al. Neurocognition in patients with brain metastases treated with radiosurgery or radiotherapy plus whole-brain irradiation: a randomised controlled trial. Lancet Oncol. 2009; 10: 1037–1044.
7.Brown, PD, Jaeckle, K, Ballman, KV, et al. Effect of radiosurgery alone vs radiosurgery with whole brain radiation therapy on cognitive function in patients with 1 to 3 brain metastases: a randomized clinical trial. J Am Med Assoc. 2016; 316(4): 401–409.
8.Sun, A, Bae, K, Gore, EM, et al. Phase III trial of prophylactic cranial irradiation compared with observation in patients with locally advanced non-small-cell lung cancer: neurocognitive and quality-of-life analysis. J Clin Oncol. 2011; 29(3): 279–286.
9.Nayak, L, Lee, EQ, Wen, PY. Epidemiology of brain metastases. Curr Oncol Rep. 2012; 14: 48–54.
10.Barnholtz-Sloan, JS, Sloan, AE, Davis, FG, Vigneau, FD, Lai, P, Sawaya, RE. Incidence proportions of brain metastases in patients diagnosed (1973 to 2001) in Metropolitan Detroit Cancer Surveillance System. J Clin Oncol. 2004; 22: 2865–2872.
11.Soltys, SG, Adler, JR, Lipani, JD, et al. Stereotactic radiosurgery of the postoperative resection cavity for brain metastases. Int J Radiat Oncol Biol Phys. 2008; 70: 187–193.
12.Kelly, PJ, Lin, YB, Yu, AY, et al. Stereotactic irradiation of the postoperative resection cavity for brain metastasis: a frameless linear accelerator-based case series and review of the technique. Int J Radiat Oncol Bio Phys. 2012; 82: 95–101.
13.Choi, CY, Chang, SD, Gibbs, IC, et al. Stereotactic radiosurgery of the postoperative resection cavity for brain metastases: prospective evaluation of target margin on tumor control. Int J Radiat Oncol Bio Phys. 2012; 84: 336–342.
14.Hartford, AC, Paravati, AJ, Spire, WJ, et al. Postoperative stereotactic radiosurgery without whole-brain radiation therapy for brain metastases: potential role of preoperative tumor size. Int J Radiat Oncol Bio Phys. 2013; 85: 650–655.
15.Brennan, C, Yang, TJ, Hilden, P, et al. A phase 2 trial of stereotactic radiosurgery boost after surgical resection for brain metastases. Int J Radiat Oncol Biol Phys. 2014; 88: 130–136.
16.Lamba, N, Muskens, IS, DiRisio, AC, et al. Stereotactic radiosurgery verse whole-brain radiotherapy after intracranial metastasis resection: a systematic review and meta-analysis. Radiat Oncol. 2017; 12: 106.
17.Iorio-Morin, C, Masson-Côté, L, Ezahr, Y, Blanchard, J, Ebacher, A, Mathieu, D. Early gamma knife stereotactic radiosurgery to the tumor bed of resected brain metastasis for improved local control. J Neurosurg. 2014; 121 (suppl), 69–74.
18.Smith, TR, Lall, RR, Lall, RR, et al. Survival after surgery and stereotactic radiosurgery for patients with multiple intracranial metastases: results of a single-center retrospective study. J Neurosurg. 2014; 121: 839–845.
19.Mahajan, A, Ahmed, S, McAleer, MF, et al. Prospective randomized trial of post-operative stereotactic radiosurgery versus observation for completely resected brain metastases. Lancet Oncol. 2017; 18(8): 1040–1048.
20.Shaw, E, Kline, R, Gillin, M, et al. Radiation therapy oncology group: radiosurgery quality assurance guidelines. Int J Radiat Oncol Biol Phys. 1993; 27: 1231–1239.
21.Patchell, RA, Tibbs, PA, Walsh, JW, et al. A randomized trial of surgery in the treatment of single metastases to the brain. N Engl J Med. 1990; 322: 494–500.
22.Deangelis, LM, Delattre, JY, Posner, JB. Radiation-induced dementia in patients cured of brain metastases. Neurology. 1989; 39: 789–796.
23.Nieder, C, Schwerdtfeger, K, Steudel, WI, Schnabel, K. Patterns of relapse and late toxicity after resection and whole-brain radiotherapy for solitary brain metastases. Strahlenther Onkol. 1998; 174: 275–278.
24.Meyers, CA, Smith, JA, Bezjak, A, et al. Neurocognitive function and progression in patients with brain metastases treated with whole-brain radiation and motexafin gadolinium: results of a randomized trial phase III trial. J Clin Oncol. 2004; 22: 157–165.
25.Soliman, H, Ruschin, M, Angelov, L, et al. Consensus contouring guidelines for postoperative completely resected cavity stereotactic radiosurgery for brain metastases. Int J Radiat Oncol Bio Phys. 2018; 100: 436–442.
26.Wang, CC, Floyd, SR, Chang, CH, et al. Cyberknife Hypofractionated Stereotactic Radiosurgery (HSRS) of resection cavity after excision of larger cerebral metastasis: efficacy and safety of an 800 cGy x3 daily fractions regimen. J Neurooncol. 2012; 106: 601–610.
27.Steinmann, D, Maertens, B, Janssen, S, et al. Hypofractionated stereotactic radiotherapy (hfSRT) after tumour resection of a single brain metastasis: report of a single-centre individualized treatment approach. J Cancer Res Clin Oncol. 2012; 138: 1523–1529.
28.Minniti, G, Scaringi, C, Paolini, S, et al. Single-fraction verse multifraction (3 × 9 Gy) stereotactic radiosurgery for large (>2 cm) brain metastases: a comparative analysis of local control and risk of radiation-induced brain necrosis. Int J Radiat Oncol Bio Phys. 2016; 95: 1142–1148.
29.Zhong, J, Ferris, MJ, Switchenko, J, et al. Postoperative stereotactic radiosurgery for resected brain metastases: a comparison of outcomes for large resection cavities. Pract Radiat Oncol. 2017; 7(6): e419–e425.